News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dehaier Medical Systems Ltd. (DHRM) Announces Strategic Mutual Cooperation Agreement with HEYER Medical AG



6/18/2012 12:00:53 PM

BEIJING, June 18, 2012 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that the Company has entered into a three-year strategic mutual cooperation agreement with HEYER Medical AG ("Heyer"), an internationally recognized, Germany-based company specializing in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment. Management of both parties participated in the signing ceremony at Dehaier's headquarters in Beijing on June 5, 2012.

(Logo: http://photos.prnewswire.com/prnh/20100422/CNTH001LOGO)

According to the Agreement, Dehaier will continue to be one of the key distributors for Heyer's anesthesia machines and exclusive distributor of nebulizers in China. Heyer's anesthesia machines and inhalation equipment currently holds a large market share in China, and Dehaier believes that there are a number of significant growth opportunities for Heyer's products throughout the country. As Heyer's distributor, Dehaier will continue leveraging its solid professional sales force and strong customer base to promote and market Heyer's products. In addition to distributing Heyer's products in China, Dehaier will also provide medical products and technical services for Heyer, delivering high quality, cost-effective products to the majority of countries that Heyer serves, predominantly in Asia, East Asia and Africa.

Dehaier's CEO, Mr. Ping Chen stated, "We continue to build long-lasting relationships with many of the industry's most renowned medical manufacturers. I met with Mr. Klaus Schickhaus, CEO of Heyer Medical in Beijing last year, and he also showed great interest in Dehaier's homecare market portfolio and is reviewing opportunities for potential joint cooperation. We are delighted to be working with Heyer and welcome this opportunity for Dehaier to strengthen our international market expansion, enhance our brand awareness, improve our R&D capability, and eventually realize substantial growth in revenue for the benefit of our shareholders."

About Heyer Medical

Founded in 1883, Heyer became an innovator in inhalation technology for the treatment of respiratory tract diseases. Today Heyer is an internationally acknowledged specialist in state-of-the-art inhalation and anesthesia equipment, oxygen concentrators, breathing therapy equipment and connecting equipment. The products are used all over the world, particularly in the medical field, in clinics and practices in Europe and Asia as well as in the Middle East, South America and the USA. Their inhalation equipment is also increasingly used in wellness applications and for treatment and care at home.

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents and five software copyrights; additionally Dehaier has two pending software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn.

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular statements about Dehaier's agreement with Heyer. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Contact Us

Dehaier Medical Systems Limited
Surie Liu
+86 10-5166-0080
lius@dehaier.com.cn

Dehaier Medical Systems Limited
Tina He
+86 10-5166-0080
hexw@dehaier.com.cn

The Equity Group Inc.
Katherine Yao
+86 10-6587-6435
kyao@equityny.com

In America
The Equity Group Inc.
Adam Prior
(212) 836-9606
aprior@equityny.com

SOURCE Dehaier Medical Systems Ltd.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES